TNF-R1 Blocking Peptide
Catalog number
3125BP-50
Name
TNF-R1 Blocking Peptide
Size
50 μg
Price
245.00 EUR
Supplier
Details
Antibody Target
TNF-R1
Accession
P25118
Gene ID
21937
Appearance
Colorless liquid
Concentration
0.2 mg/ml
Formulation
50 µg (0.2 mg/ml) in phosphate buffered saline (PBS), pH 7.2, containing 50% glycerol, 1% BSA and 0.02% thimerosal.
Packaging
EA
Storage Temp.
-20 °C
Shipping
gel pack
Shelf Life
1 year
Category
TNF
Research Use
For Rersearch Use Only! Not to be used in humans.
Handling
The peptide solution should be gently mixed before use.
Test
You can block the antibody by the specific target amino acid sequence of peptide.
Properties
blocking peptide
Description
Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
Gene
Tumor necrosis factor (TNFa, tumor necrosis factor alpha, TNFα, cachexin, or cachectin) is a cell signaling protein (cytokine) involved in systemic inflammation and is one of the cytokines that make up the acute phase reaction. It is produced chiefly by activated macrophages, although it can be produced by many other cell types such as CD4+ lymphocytes, NK cells, neutrophils, mast cells, eosinophils, and neurons. TNFb or TNF beta also bin on TNF receptors for Th1 activation.